John Gill Insider Profile
11 Followers
John Gill, Director at Altimmune, holds 21.70K shares in Altimmune (Ticker: ALT), holds 40.31K shares in Tetralogic Pharma (Ticker: TLOG). Most recently, John Gill Bought ― shares of Altimmune on Apr 06, 2026 for an estimated value of $31.28K.
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-64.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by John Gill
John Gill's Trading History
Altimmune
Apr 06, 2026
Director
Informative Buy
31.28K
$70.09K
Tetralogic Pharma
Dec 11, 2013
Director
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see John Gill's performance on stock
You May Also Like
John Gill insider profile FAQ
What is the percentage of profitable transactions made by John Gill?
The percentage of profitable transactions made by John Gill is 0%.
What is the average return per transaction made by John Gill?
The average return per transaction made by John Gill is -64.20%.
What stocks does John Gill hold?
John Gill holds: ALT, TLOG stocks.
What was John Gill’s latest transaction?
John Gill latest transaction was an Informative Buy of $31.28K.
What was John Gill's most profitable transaction?
John Gill’s most profitable transaction was an Informative Buy of ALT stock on December 23, 2025. The return on the trade was -12.50%.
What is John Gill's role in Altimmune?
John Gill's role in Altimmune is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.